These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 35101110

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.
    Patikulsila D, Winaikosol P, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Kunavisarut P.
    BMC Ophthalmol; 2022 Oct 27; 22(1):411. PubMed ID: 36303103
    [Abstract] [Full Text] [Related]

  • 25. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
    Avcı R, Mavi Yıldız A, Çınar E, Yılmaz S, Küçükerdönmez C, Akalp FD, Avcı E.
    Turk J Ophthalmol; 2021 Feb 25; 51(1):38-44. PubMed ID: 33631914
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H, Bardak Y, Erçalık Y, Erdem B, Arslan G, Timlioglu S.
    Eur J Ophthalmol; 2018 May 25; 28(3):306-310. PubMed ID: 29148027
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
    Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U, VIEW 1 and VIEW 2 Study Groups.
    Ophthalmology; 2012 Dec 25; 119(12):2537-48. PubMed ID: 23084240
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of subretinal aflibercept vs ranibizumab vs bevacizumab in the context of PPV, pneumatic displacement with subretinal air and subretinal tPA in naïve submacular haemorrhage secondary to nAMD. "The Submarine Study".
    Iglicki M, Khoury M, Donato L, Quispe DJ, Negri HP, Melamud JI.
    Eye (Lond); 2024 Feb 25; 38(2):292-296. PubMed ID: 37537388
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.
    Retina; 2013 Apr 25; 33(4):846-53. PubMed ID: 23400079
    [Abstract] [Full Text] [Related]

  • 34. The effect of initial intravitreal tissue plasminogen activator and gas injection on vision improvement in patients with submacular haemorrhage associated with age-related macular degeneration.
    Lee SH, Lee SJ, Shin YI, Lim HB, Kim JY, Han YS, Nam KY.
    Eye (Lond); 2021 Nov 25; 35(11):3064-3070. PubMed ID: 33423044
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Simultaneous intravitreal aflibercept and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Wakabayashi T, Hara C, Shiraki A, Shiraki N, Sayanagi K, Sakimoto S, Sato S, Sakaguchi H, Nishida K.
    Graefes Arch Clin Exp Ophthalmol; 2023 Jun 25; 261(6):1545-1552. PubMed ID: 36473986
    [Abstract] [Full Text] [Related]

  • 37. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F, Klatt C, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2010 Jan 25; 94(1):48-53. PubMed ID: 19946027
    [Abstract] [Full Text] [Related]

  • 38. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ, Ho-Yen G, Clarke B, Barbara R, Lash S, Papathomas T, Antonakis S, Gupta B.
    Eur J Ophthalmol; 2021 Mar 25; 31(2):643-648. PubMed ID: 31813290
    [Abstract] [Full Text] [Related]

  • 39. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
    Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ.
    Korean J Ophthalmol; 2015 Oct 25; 29(5):315-24. PubMed ID: 26457037
    [Abstract] [Full Text] [Related]

  • 40. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M, Karabaş VL, Aslan MS, Kara Ö, Karaman S, Yenihayat F.
    Indian J Ophthalmol; 2017 Jun 25; 65(6):482-487. PubMed ID: 28643713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.